Global Antibody Discovery and Development Services Market Growth (Status and Outlook) 2024-2030

Global Antibody Discovery and Development Services Market Growth (Status and Outlook) 2024-2030

Antibody Discovery and Development Services refers to professional services for the research and development of new therapeutic antibodies. These services are typically provided by biotech companies, contract research organizations (CROs), or specialized antibody development facilities. These services are designed to help customers comprehensively advance the development of therapeutic antibodies from the early stages of antibody discovery to preclinical research and clinical trials. These services often require a combination of professional scientific knowledge and advanced experimental techniques, as well as a quality management system that meets regulatory standards to ensure the high quality and safety of the antibodies.

The global Antibody Discovery and Development Services market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Antibody Discovery and Development Services Industry Forecast” looks at past sales and reviews total world Antibody Discovery and Development Services sales in 2023, providing a comprehensive analysis by region and market sector of projected Antibody Discovery and Development Services sales for 2024 through 2030. With Antibody Discovery and Development Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibody Discovery and Development Services industry.

This Insight Report provides a comprehensive analysis of the global Antibody Discovery and Development Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Antibody Discovery and Development Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Antibody Discovery and Development Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibody Discovery and Development Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibody Discovery and Development Services.

United States market for Antibody Discovery and Development Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Antibody Discovery and Development Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Antibody Discovery and Development Services is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Antibody Discovery and Development Services players cover Abcam, Abzena, AlivaMab Biologics, Alloy Therapeutics and Antibody Solutions, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Antibody Discovery and Development Services market by product type, application, key players and key regions and countries.

Segmentation by type
Antibody Discovery Services
Antibody Production Services

Segmentation by application
Pharmaceutical
Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abcam
Abzena
AlivaMab Biologics
Alloy Therapeutics
Antibody Solutions
Aragen Bioscience
Aurigene Pharmaceutical Services
Biocytogen
Biomolecular Discovery Services
Biotem
Charles River Laboratories
ChemPartner
Creative Bioarray
Creative Biolabs
Curia
Eurofins
Evotec
GenScript
Integrated DNA Technologies
LakePharma
MorphoSys
NanoCellect
ProteoGenix
Rapid Novor
Sanofi
Syd Labs
Twist Bioscience
Yumab
Viva Biotech
WuXi Biologics

Please note: The report will take approximately 2 business days to prepare and deliver.